Gabather

www.gabather.com

Gabather (abbreviated form of GABA Therapeutics) focuses on the development of highly potent and selective GABAA receptor modulators targeting the principal inhibitory neurotransmitter in the mammalian brain, gamma aminobutyric acid (GABA). Our drug development candidates are small molecular weight compounds designed through proprietary pharmacophore modelling. Our development pipeline includes candidates targeting the GABAA receptor in both preclinical and clinical development and we aim to produce novel pharmaceuticals such as antipsychotics, antidepressants, anxiolytics, analgesics and cognitive enhancers to treat CNS diseases with high unmet need.

Read more

Reach decision makers at Gabather

Lusha Magic

Free credit every month!

Gabather (abbreviated form of GABA Therapeutics) focuses on the development of highly potent and selective GABAA receptor modulators targeting the principal inhibitory neurotransmitter in the mammalian brain, gamma aminobutyric acid (GABA). Our drug development candidates are small molecular weight compounds designed through proprietary pharmacophore modelling. Our development pipeline includes candidates targeting the GABAA receptor in both preclinical and clinical development and we aim to produce novel pharmaceuticals such as antipsychotics, antidepressants, anxiolytics, analgesics and cognitive enhancers to treat CNS diseases with high unmet need.

Read more
icon

Country

icon

City (Headquarters)

Södertälje

icon

Employees

1-10

icon

Founded

2014

icon

Social

  • icon

Employees statistics

View all employees

Potential Decision Makers

  • Chief Executive Officer

    Email ****** @****.com
    Phone (***) ****-****
  • Member Board of Directors

    Email ****** @****.com
    Phone (***) ****-****
  • Member of Nomination Committee

    Email ****** @****.com
    Phone (***) ****-****

Reach decision makers at Gabather

Free credits every month!

My account

Sign up now to uncover all the contact details